Prostamax 20 mg

Prostamax peptide is a synthetic short peptide bioregulator developed within the Khavinson school of biogerontology research. It is classified as a prostate-tropic tetrapeptide, designed to model the action of naturally occurring tissue-derived peptides isolated from prostatic epithelium. In peptide research, Prostamax is studied as a tissue-selective compound for examining how short peptides interact with prostatic epithelial cells, modulate transcriptional activity, and influence age-related shifts in prostate-tissue biology.

At the molecular level, Prostamax is investigated for its ability to engage prostate epithelial cells and modulate gene expression patterns associated with cell differentiation, proliferation balance, and cellular-renewal signaling. Khavinson-school research has proposed that short bioregulators such as Prostamax penetrate cell and nuclear membranes and bind to specific DNA regions, thereby influencing the transcription of genes linked to tissue-specific protein synthesis. This selective signaling profile makes Prostamax a useful model for studying how short peptides regulate epithelial homeostasis under conditions of cellular aging and oxidative load.

Research interest in Prostamax peptide has centered on prostate-tissue renewal models, age-related prostatic biology, and the broader concept of peptide bioregulation in aging. Foundational work on the Khavinson family of bioregulators has linked short peptides of this type to normalization of tissue-specific gene expression, restoration of cellular function in aged research models, and improved markers of epithelial integrity (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). These findings position Prostamax as a relevant research compound in investigations of prostatic-epithelium signaling, tissue-specific peptide regulation, and age-related epithelial decline.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

See also: Cartalax 20 mg, Testagen, and Crystagen 20 mg.

Specifications

• Purity: 99%
• Quantity: 20 mg
• Molecular Formula: C₂₀H₃₃N₅O₉
• Molecular Weight: 487.5 g/mol